Machine Learning and Artificial Intelligence in <scp>PK‐PD</scp> Modeling: Fad, Friend, or Foe?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Machine Learning and Artificial Intelligence in PK‐PD Modeling: Fad, Friend, or Foe?

Published:2024-01-05 Issue:4 Volume:115 Page:652-654
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Huang Zhonghui¹,Denti Paolo²^ORCID,Mistry Hitesh³^ORCID,Kloprogge Frank⁴^ORCID

Affiliation:

1. Great Ormond Street Institute of Child Health University College London London UK

2. Division of Clinical Pharmacology, Department of Medicine University of Cape Cape Town South Africa

3. Division of Pharmacy University of Manchester Manchester UK

4. Institute for Global Health University College London London UK

Publisher

Wiley

Link

https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3165

Reference10 articles.

1. Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin

2. A Machine Learning Approach to Predict Interdose Vancomycin Exposure

3. XGBoost-based machine learning test improves the accuracy of hemorrhage prediction among geriatric patients with long-term administration of rivaroxaban

4. A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation

5. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape;Drugs;2024-09-06

2. Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability;CPT: Pharmacometrics & Systems Pharmacology;2024-06-14

3. Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine;Clinical Pharmacology & Therapeutics;2024-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3